Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia.
Dwivedi
Sanjeev
S
Pavuluri
Mani
M
Heidenreich
Jodi
J
Wright
Tom
T
D000293:Adolescent; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D016666:Fluvoxamine / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000209:etiology*; D018967:Risperidone / Q000008:administration & dosage / Q000627:therapeutic use; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use*
D018492:Dopamine Antagonists; D016666:Fluvoxamine; D018967:Risperidone; D017367:Selective Serotonin Reuptake Inhibitors